Henrik Schrøeder
About
Henrik Schrøeder is a scholar working on Pediatrics, Perinatology and Child Health, Neurology and Public Health, Environmental and Occupational Health.
According to data from OpenAlex, Henrik Schrøeder has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pediatrics, Perinatology and Child Health, 12 papers in Neurology and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Henrik Schrøeder's work include Childhood Cancer Survivors' Quality of Life (14 papers), Neuroblastoma Research and Treatments (12 papers) and Acute Lymphoblastic Leukemia research (9 papers). Henrik Schrøeder is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (14 papers), Neuroblastoma Research and Treatments (12 papers) and Acute Lymphoblastic Leukemia research (9 papers). Henrik Schrøeder collaborates with scholars based in Denmark, Austria and United Kingdom. Henrik Schrøeder's co-authors include Marianne Brodmann, Curt Peterson, Martin Werner, Peter Reimer, Michael R. Jaff, Karsten Krüger, Kjeld Schmiegelow, Dirk-Roelfs Meyer, Freidoun Albertioni and Charlotte Ulrikka Rask and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.
In The Last Decade
Henrik Schrøeder
39 papers receiving 1.1k citations
Peers
Henrik Schrøeder
Furqan Shaikh Canada
Girish Chinnaswamy India
Joe C. Files United States
Patrick Hilden United States
Alessandro Anselmo Italy
N. Caeyers Italy
M. Gospodarowicz Canada
Cynthia L. Toze Canada
David Rea United States
Rajiv Shah Germany
Citations per year, relative to Henrik Schrøeder Henrik Schrøeder (= 1×)
peers
Furqan Shaikh
Countries citing papers authored by Henrik Schrøeder
Since
Specialization
Citations
This map shows the geographic impact of Henrik Schrøeder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Schrøeder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Schrøeder more than expected).
Fields of papers citing papers by Henrik Schrøeder
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Henrik Schrøeder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Schrøeder. The network helps show where Henrik Schrøeder may publish in the future.
Co-authorship network of co-authors of Henrik Schrøeder
This figure shows the co-authorship network connecting the top 25 collaborators of Henrik Schrøeder. A scholar is included among the top collaborators of Henrik Schrøeder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrik Schrøeder. Henrik Schrøeder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Bosiers, Michel, Thomas Rand, Raman Uberoi, et al.. (2025). MOTIV Bioresorbable Scaffold in Below-The-Knee Artery Disease: European Post-Market Pilot BTK Trial: 36-Month Results. CardioVascular and Interventional Radiology. 48(11). 1576–1586.
2.
Lyden, Sean P., Marianne Brodmann, Henrik Schrøeder, et al.. (2023). Five-Year Independent Patient-Level Mortality Analysis of the Pooled ILLUMENATE Pivotal and EU Randomized Controlled Trials. Journal of the Society for Cardiovascular Angiography & Interventions. 2(4). 100634–100634.
3.
Lyden, Sean P., Marianne Brodmann, Sahil A. Parikh, et al.. (2021). Four-year patient-level pooled mortality analysis of the ILLUMENATE US Pivotal and EU randomized controlled trials. Journal of Vascular Surgery. 75(2). 600–607.
4.
Wolff, Sanne Lausen, Christian Fynbo Christiansen, Søren Paaske Johnsen, et al.. (2021). Inequality in place-of-death among children: a Danish nationwide study. European Journal of Pediatrics. 181(2). 609–617.
5.
Tepe, Gunnar, Henrik Schrøeder, Thomas Albrecht, et al.. (2020). Paclitaxel-Coated Balloon vs Uncoated Balloon Angioplasty for Treatment of In-Stent Restenosis in the Superficial Femoral and Popliteal Arteries: The COPA CABANA Trial. Journal of Endovascular Therapy. 27(2). 276–286.
6.
Tepe, Gunnar, Thomas Zeller, Jean-Marc Corpataux, et al.. (2020). Paclitaxel-Coated Balloon for the Treatment of Infrainguinal Disease: 12-Month Outcomes in the All-Comers Cohort of BIOLUX P-III Global Registry. Journal of Endovascular Therapy. 27(2). 304–315.
7.
Wolff, Sanne Lausen, Christian Fynbo Christiansen, Søren Paaske Johnsen, et al.. (2020). Disparities in intensity of treatment at end‐of‐life among children according to the underlying cause of death. Acta Paediatrica. 110(5). 1673–1681.
8.
Wolff, Sanne Lausen, Christian Fynbo Christiansen, Mette Kjærgaard Nielsen, et al.. (2020). Predictors for place of death among children:A systematic review and meta-analyses of recent literature. European Journal of Pediatrics. 179(8). 1227–1238.
9.
Kristensen, Kim, Henrik Schrøeder, Peder Skov Wehner, et al.. (2019). Plasma creatinine as predictor of delayed elimination of high‐dose methotrexate in childhood acute lymphoblastic leukemia: A Danish population‐based study. Pediatric Blood & Cancer. 66(6). e27637–e27637.
10.
Brodmann, Marianne, Martin Werner, Dirk-Roelfs Meyer, et al.. (2018). Sustainable Antirestenosis Effect With a Low-Dose Drug-Coated Balloon. JACC: Cardiovascular Interventions. 11(23). 2357–2364.
11.
Garaventa, Alberto, Ulrike Pöetschger, Dominique Valteau‐Couanet, et al.. (2018). The randomised induction for high-risk neuroblastoma comparing COJEC and N5-MSKCC regimens: Early results from the HR-NBL1.5/SIOPEN trial.. Journal of Clinical Oncology. 36(15_suppl). 10507–10507.
12.
Ladenstein, Ruth, Ulrike Pöetschger, D. Couanet, et al.. (2018). Immunotherapy with anti-GD2 antibody ch14.18/CHO±IL2 within the HR-NBL1/SIOPEN trial to improve outcome of high-risk neuroblastoma patients compared to historical controls.. Journal of Clinical Oncology. 36(15_suppl). 10539–10539.
13.
Wehner, Peder Skov, et al.. (2012). Palonosetron for the prevention of nausea and vomiting in children with acute lymphoblastic leukemia treated with high dose methotrexate. Pediatric Blood & Cancer. 59(5). 870–873.
14.
Kristensen, Brian, et al.. (2011). Hydrochloric Acid Treatment of Tunneled Central Venous Catheter Infections in Children With Cancer. Journal of Pediatric Hematology/Oncology. 33(2). e64–e68.
15.
Cadwell, Kevin, Jeanette Falck Winther, E. Janet Tawn, et al.. (2010). The heritability of G2chromosomal radiosensitivity and its association with cancer in Danish cancer survivors and their offspring. International Journal of Radiation Biology. 86(11). 986–995.
16.
Tawn, E. Janet, Gwen S. Rees, Jeanette Falck Winther, et al.. (2010). Germline minisatellite mutations in survivors of childhood and young adult cancer treated with radiation. International Journal of Radiation Biology. 87(3). 330–340.
17.
Schmiegelow, Kjeld, et al.. (2008). Influence of methylene tetrahydrofolate reductase polymorphisms and coadministration of antimetabolites on toxicity after high dose methotrexate. European Journal Of Haematology. 81(5). 391–398.
18.
Saarinen‐Pihkala, Ulla M., Carsten Heilmann, Jacek Winiarski, et al.. (2006). Pathways Through Relapses and Deaths of Children With Acute Lymphoblastic Leukemia: Role of Allogeneic Stem-Cell Transplantation in Nordic Data. Journal of Clinical Oncology. 24(36). 5750–5762.
19.
Schrøeder, Henrik, Konstantinos Kamperis, Niels Grunnet, & Peter Hokland. (2005). Prediction of target CD34 positive cells following leukopheresis in children with neuroblastoma. Pediatric Blood & Cancer. 46(7). 786–792.
20.
Rask, Charlotte Ulrikka, Freidoun Albertioni, Søren M. Bentzen, Henrik Schrøeder, & Curt Peterson. (1998). Clinical and Pharmacokinetic Risk Factors for High-dose Methotrexate-induced Toxicity in Children with Acute Lymphoblastic Leukemia: A Logistic Regression Analysis. Acta Oncologica. 37(3). 277–284.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Furqan Shaikh Breakdown of academic impact, for papers by Girish Chinnaswamy Breakdown of academic impact, for papers by Joe C. Files Breakdown of academic impact, for papers by Patrick Hilden Breakdown of academic impact, for papers by Alessandro Anselmo Breakdown of academic impact, for papers by N. Caeyers Breakdown of academic impact, for papers by M. Gospodarowicz Breakdown of academic impact, for papers by Cynthia L. Toze Breakdown of academic impact, for papers by David Rea Breakdown of academic impact, for papers by Rajiv Shah